TB and Outbreaks Week
Susan Hasty, Publisher
Table of Contents . . . October 16th, 2001
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in TB and Outbreaks Week | Other Publications
Kidney Disease - Diabetes, Cyclosporine Use Are Risk Factors For Posttransplant Tuberculosis
Tuberculous Kyphosis - Single-Stage Decompression Surgery Effective
AIDS/HIV Tuberculosis - Italian Prevention Guidelines Effective, But Underused
Drug Development - Antiviral Peptides Potentially Useful Against STDs
Mycobacterial Infection - Immune Response Includes Matrix Metalloproteinase Production
Pesticide Poisoning - Illnesses Associated With Use Of Plant Growth Regulator
Poliomyelitis - Total of 34 Cases, 2 Fatalities Reported In Hispaniola, Dominican Republic
Anthrax - Case In Florida Appears To Be Isolated Event
At-Risk Populations - Oral Piercings Gaining Popularity
Bioterriorism - Emergency Officers Meet To Discuss Options
Bioterrorism - Experts: United States Is Unprepared For Germ Attack
Bioterrorism - Learn Ways To Protect Your Family
Blood Donation - Want to Give Blood? First See If You Are Eligible
Chronic Obstructive Pulmonary Disease - Survey Shows Patients May Be Suffering Needlessly
Cystic Fibrosis - Clinical Development Grant Supports Mucoregulator Therapy Research
Drug Development - Phase III Data Suggests Antibiotic Is Better Than Standard Therapy
Foot and Mouth Disease - Earlier Culling Would Have Dramatically Reduced Epidemic
Idiopathic Respiratory Distress Syndrome - Phase III Clinical Trial Launched In Europe And U.S.
Infectious Disease - Plexus Vaccine Licenses Molsoft To Develop Proprietary Virtual Epitope Databases
Influenza - Aventis Pasteur To Complete Flu Vaccine Shipments By November
Obstructive Airway Disease - Long-Acting Bronchodilator Moves Into Pivotal Studies
Prevention - Chemical, Biotech Firms Strengthen Security Against Bioterrorism
Rabies - LigoCyte Pharmaceuticals Collaborates With NIH To Develop Mucosal Vaccine
Respiratory Infections - Aventis, ViroPharma Form U.S. Collaboration For Drug Against Common Cold
Yersinia Pestis - Plague Bacterium Genome Sequenced
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
